Digital Diabetes Management Market, By Type , By Product, By Geography

Description

Digital Diabetes Management Market is estimated to be valued at USD 17.14 Bn in 2026 and is expected to reach USD 71.77 Bn by 2033, growing at a compound annual growth rate (CAGR) of 22.7% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 17.14 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	22.70%	2033 Value Projection:	USD 71.77 Bn

Digital diabetes management devices, like smart insulin pens, smart insulin pumps, smart glucose meter, and continuous blood glucose monitoring devices, help people with diabetes (type I and II) to monitor and manage their glucose levels. Thus, with the increasing prevalence of diabetes across the globe, the demand for technologically advanced diabetes management devices (digital diabetes management devices) is also increasing with a rapid pace.

Market Dynamics

Rise in burden of diabetes, growing geriatric population, introduction of artificial intelligence (AI) in diabetes management devices, increasing demand for digital diabetes management devices, and increasing awareness among people about diabetes care and benefits of technologically advanced diabetes management devices are major factors expected to propel the growth of the global digital diabetes management market over the forecast period.

For instance, in November 2022, Eli Lilly and Company (LLY) planned to rollout first connected platform, the Tempo Personalized Diabetes Management Platform, in the U.S. The platform aims to help individuals living with type 1 or type 2 diabetes and clinicians make informed, data-backed decisions to manage treatment with Lilly insulins.

Moreover, in March 2022, India Medtronic Private Limited announced the launch of the MiniMed 780G system in India. The MiniMed 780G system is a next generation closed loop insulin pump system for the treatment of type 1 diabetes in people age 7 to 80 years.

Key features of the study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global digital diabetes management market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Abbott Laboratories, Acon Laboratories, Inc., Bayer AG, F. Hoffmann-la Roche Ltd., Johnson and Johnson, Medtronic Plc, Novo Nordisk A/S, Terumo Corporation, Dexcom, Inc., and Becton, Dickinson and Company, among others.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global digital diabetes management market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global digital diabetes management market.

Market Segmentation

Global Digital Diabetes Management Market, By Type (Revenue, USD Bn, 2021 - 2033)
Handheld Devices
Wearable Devices
Global Digital Diabetes Management Market, By Product (Revenue, USD Bn, 2021 - 2033)
Continuous Blood Glucose Monitoring Systems
Smart Glucose Meter
Smart Insulin Pumps
Smart Insulin Pens
Apps
Global Digital Diabetes Management Market, By Geography (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East & Africa
- GCC Countries
- Israel
- Rest of Middle East & Africa
Global Digital Diabetes Management Market: Key Companies Insights
Abbott Laboratories
Acon Laboratories, Inc.
Bayer AG
Hoffmann-la Roche Ltd.
Johnson and Johnson
Medtronic Plc
Novo Nordisk A/S
Terumo Corporation
Dexcom, Inc.
Becton, Dickinson and Company

Product Code: CMI5832

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Product
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Increasing prevalence of diabetes around the world
- High cost of digital diabetes management devices
- Increasing demand for digital management devices
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Digital Diabetes Management Market, By Type, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Handheld Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
Wearable Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)

5. Global Digital Diabetes Management Market, By Product, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Continuous Blood Glucose Monitoring Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
Smart Glucose Meter
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
Smart Insulin Pumps
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
Smart Insulin Pens
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
Apps
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)

6. Global Digital Diabetes Management Market, By Region, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(USD Bn)
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(USD Bn)
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(USD Bn)
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(USD Bn)
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(USD Bn)
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(USD Bn)

7. Competitive Landscape

Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Acon Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bayer AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
F. Hoffmann-la Roche Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Johnson and Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Medtronic Plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Novo Nordisk A/S
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Terumo Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Dexcom, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Becton, Dickinson and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Analyst Views

8. Section

Research Methodology
About us